Biosynthesis is the production of molecules by living organisms. Engineers have learned to harness these powerful biological systems to produce specific materials for humanity’s benefit. By engineering the instructions for materials’ production into the genetic code of simple organisms—e.g. bacteria, algae, yeast and other fungi—they can acquire the novel ability to produce molecules they usually wouldn’t. A cornerstone technology of the bio revolution.

Renew Biopharma Inc is a research company developing proprietary therapeutics to treat neurodegenerative diseases, traumatic brain injuries (TBI), and for pain management. CEO Mike Mendez provides an introduction to the company and explains its interest in developing treatments using biosynthetic cannabinoids.

SAN FRANCISCO -- (BUSINESS WIRE) -- Michael Mendez, Renew Biopharma founder and CEO, and long-time biotech industry pioneer, will speak tomorrow about his company’s quest to look beyond the Cannabis plant to discover and develop “a new world of novel therapeutics” at SynBioBeta 2018.